News

OGXI

What's Done Better for Investors: Small Biotechs or Big Pharma?

The Life Sciences Report | Equities.com |

When the biotechnology market hit a speed bump in early 2014, every stock in the sector was jolted. Large-cap biotech and big pharma have largely recovered, but small- and micro-cap companies


Biotech Watchlist 2014: Sound Science, Innovative Ideas and a Sprinkle of Pixie Dust

The Life Sciences Report | Equities.com |

2013 was a banner year for the life sciences sector, with biotech, pharmaceutical and medtech companies buoyed by advances in therapeutic techniques, a friendly regulatory environment, lucrative


Six Underperforming Biotech Stocks Analysts Love: An Update

Jacob Harper | Equities.com |

At Equities.com we’re interested in the disparity between performance and analyst proselytizing, which inspired us back in June to look at six specific biotech plays that had lost value on


6 Biotech Stocks That Investors Hate but Analysts Love

Jacob Harper | Equities.com |

Sometimes there are stocks that take a beating, but for whatever reason, the analysts won’t let them go. We decided to look at stocks that have had a rough go, but according to the analysts, are


Equities Sector Coverage: Stocks Fade in Late Trading to End Lower

Sector Recap | Equities.com |

The S&P/Case-Shiller 20-city composite index of home prices showed a decline of 0.8% in January, a slightly bigger decline than expected. Home prices were down 3.8% year over year. The


Sponsored Financial Content

Market Movers